CYP19A1 and glioblastoma: For example, the coating of nanoparticles with the anti-GD2-ch14.18/CHO mAb allowed the delivery of a specific the aromatase inhibitor, Letrozole, in GBM, inducing reduced proliferation, migration, and chemoresistance in patient-derived GBM tumors [106].